Ratio of IC50 for antimalarial activity against CQ-sensitive Plasmodium falciparum 3D7 incubated for 72 hrs by SYBR Green-1 dye based fluorescence assay to Plasma concentration in NIH mouse infected with Plasmodium chabaudi ASS at 10 mg/kg, po qd for 4 days starting from 4 hrs post-parasite inoculation and measured at 24 hrs post-dosing on day 4 by LC/MS analysis
Ratio of IC50 for antimalarial activity against CQ-sensitive Plasmodium falciparum 3D7 incubated for 72 hrs by SYBR Green-1 dye based fluorescence assay to Plasma concentration in NIH mouse infected with Plasmodium chabaudi ASS at 30 mg/kg, po qd for 4 days starting from 4 hrs post-parasite inoculation and measured at 24 hrs post-dosing on day 4 by LC/MS analysis
Antimalarial activity against Plasmodium chabaudi ASS infected po dosed NIH mouse assessed as inhibition of parasitemia administered oce daily for 4 days starting from 4 hrs post parasite-inoculation and measured at 24 hrs post-last treatment by Peter's 4-day suppressive test
Plasma concentration in NIH mouse infected with Plasmodium chabaudi ASS at 30 mg/kg, po qd for 4 days starting from 4 hrs post-parasite inoculation and measured at 24 hrs post-dosing on day 4 by LC/MS analysis
Plasma concentration in NIH mouse infected with Plasmodium chabaudi ASS at 30 mg/kg, po qd for 4 days starting from 4 hrs post-parasite inoculation and measured at 6 hrs post-dosing on day 4 by LC/MS analysis
Plasma concentration in NIH mouse infected with Plasmodium chabaudi ASS at 30 mg/kg, po qd for 4 days starting from 4 hrs post-parasite inoculation and measured at 1 hr post-dosing on day 4 by LC/MS analysis
Plasma concentration in NIH mouse infected with Plasmodium chabaudi ASS at 3 mg/kg, po qd for 4 days starting from 4 hrs post-parasite inoculation and measured at 24 hrs post-dosing on day 4 by LC/MS analysis
Plasma concentration in NIH mouse infected with Plasmodium chabaudi ASS at 3 mg/kg, po qd for 4 days starting from 4 hrs post-parasite inoculation and measured at 6 hrs post-dosing on day 4 by LC/MS analysis
Plasma concentration in NIH mouse infected with Plasmodium chabaudi ASS at 3 mg/kg, po qd for 4 days starting from 4 hrs post-parasite inoculation and measured at 1 hr post-dosing on day 4 by LC/MS analysis
Plasma concentration in NIH mouse infected with Plasmodium chabaudi ASS at 10 mg/kg, po qd for 4 days starting from 4 hrs post-parasite inoculation and measured at 24 hrs post-dosing on day 4 by LC/MS analysis
Plasma concentration in NIH mouse infected with Plasmodium chabaudi ASS at 10 mg/kg, po qd for 4 days starting from 4 hrs post-parasite inoculation and measured at 6 hrs post-dosing on day 4 by LC/MS analysis
Plasma concentration in NIH mouse infected with Plasmodium chabaudi ASS at 10 mg/kg, po qd for 4 days starting from 4 hrs post-parasite inoculation and measured at 1 hr post-dosing on day 4 by LC/MS analysis
Antimalarial activity against Plasmodium chabaudi ASS infected in NIH mouse assessed as inhibition of parasitemia at 30 mg/kg, po qd for 4 days starting from 4 hrs post-parasite inoculation and measured at 24 hrs after last-drug treatment by Peter's 4-day suppressive test relative to control
Selectivity index, ratio of non-cytotoxic concentration for human HepG2 cells incubated for 72 hrs by PrestoBlue cell viability reagent based assay to IC50 for CQ-sensitive Plasmodium falciparum 3D7 incubated for 72 hrs by SYBR green1 dye based fluorescence assay
Inhibition of recombinant human CYP2C19 expressed in baculovirus infected insect cells using s-mephenytoin as substrate incubated for 30 mins in presence of NADPH-regenerating system by fluorescence based assay
Inhibition of recombinant human CYP2C9 expressed in baculovirus infected insect cells using tolbutamide as substrate incubated for 30 mins in presence of NADPH-regenerating system by fluorescence based assay